Evidence map›Paper›PMID 42616294›Full record

ArticleScience China. Life sciences2026

ZO-1-dependent fibrotic scar border formation impedes axon regeneration after spinal cord injury.

Ziyu Li, Shuisheng Yu, Xu Wang, Xiaoyang Yu, Daobao Tao, Yongqing Ma, Jiaqi Xu, Zhonghan Wu, Zhida Ma, Dasheng Tian and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ziyu Li *Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Shuisheng Yu *Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Xu Wang *Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Xiaoyang YuDepartment of Neurosurgery, Huashan Hospital Fudan University, Shanghai, 200040, China.
Daobao TaoDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Yongqing MaDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Jiaqi XuInstitute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China.
Zhonghan WuDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Zhida MaDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Dasheng TianDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Xin DingSoochow Key Laboratory of Prevention and Treatment of Child Brain Injury, Children's Hospital of Soochow University, Suzhou, 215025, China.
Meige ZhengDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Li ChengDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Yi LiInstitute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China. liyi@ion.ac.cn.
Juehua JingDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. jjhhu@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrotic scarring acutely corrals inflammation but chronically impedes axon regeneration via dense border structures after spinal cord injury (SCI). Although the origin and heterogeneity of fibroblasts have been extensively studied, effective strategies to prevent fibrotic scarring, especially the formation of its border structure, remain elusive. Here, we identified a distinct fibroblast subpopulation with markedly upregulated tight junction protein 1 (ZO-1) expression, which contributes to the formation of fibrotic scar borders after SCI. While ZO-1 has been conventionally considered restricted to epithelial/endothelial cells, our data may indicate a novel role in the formation of fibrotic scar border by platelet-derived growth factor receptor beta (PDGFRβ)-positive fibroblasts. Genetic ablation of Tjp1 (encoding ZO-1) in fibroblasts disrupted the fibrotic scar border, allowing serotonergic and tyrosine hydroxylase axons to grow into the lesion core after SCI. Disruption of the fibrotic scar border induced by ZO-1 knockout did not exacerbate inflammatory spread or damage residual neurons after SCI. Furthermore, PDGFB/PDGFRβ pathway activation induced ZO-1 expression and scar border formation in the intact spinal cord, whereas its inhibition suppressed ZO-1 upregulation and disrupted the scar border after SCI. Remarkably, combined targeting of PDGFRβ (using SU16f) and ZO-1 function (via LAT-A) synergistically promoted axonal growth across the lesion. Our findings identify ZO-1 as a critical orchestrator of the fibrotic scar border and reveal a combined therapeutic approach for enhancing axon regeneration after SCI.

Indexed as

axon regenerationfibrotic scar borderspinal cord injurytight junction protein 1

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.